Ondansetron Injection (Antiemetic)
Healthy Inc is a leading global supplier and exporter of critical care antiemetics. We provide high-purity Ondansetron Injection, manufactured in our WHO–GMP certified facilities. This highly effective 5-HT3 receptor antagonist is widely exported to hospitals, oncology centers, and surgical units in Africa, LATAM, CIS, and Southeast Asia for the prevention and treatment of severe nausea and vomiting.
Product Overview
Ondansetron is a potent and selective 5-HT3 Receptor Antagonist. It blocks the action of serotonin, a natural substance that may cause nausea and vomiting.
It is the “Drug of Choice” for:
- CINV: Chemotherapy-Induced Nausea and Vomiting (Standard of care for cancer patients).
- PONV: Post-Operative Nausea and Vomiting (Used prophylactically before anesthesia).
- RINV: Radiation-Induced Nausea and Vomiting.
Product Composition & Strength
We supply this product in sterile ampoules and vials.
| Active Ingredient | Strength | Total Content |
|---|---|---|
| Ondansetron Hydrochloride | 2 mg / ml | 4 mg / 2 ml (Ampoule) |
| Ondansetron Hydrochloride | 2 mg / ml | 8 mg / 4 ml (Vial/Ampoule) |
*Preservative-free formulation available for pediatric use.
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers and Hospital Tenders.
| HS Code | 3004.90.99 (Medicaments for therapeutic uses) |
| Dosage Form | Liquid Injection (Parenteral) |
| Route of Administration | Intravenous (IV) Slow Push / Intramuscular (IM) |
| Packaging | 2ml / 4ml Ampoules (Tray/Blister Pack) |
| Storage | Store below 30°C. Protect from light. |
| Certificates | WHO-GMP, COPP, FSC, CTD Dossier |
Manufacturing Authority
Manufactured at our WHO-GMP & ISO 9001:2015 certified unit.
- Sterility: Manufactured using aseptic filtration to ensure safety for immunocompromised cancer patients.
- Stability: Formulation is pH-stabilized to prevent degradation during storage.
- Capacity: High-volume production for hospital bulk contracts.
Therapeutic Indications
Indicated for the prevention and treatment of nausea and vomiting associated with:
- Initial and repeat courses of emetogenic cancer chemotherapy (e.g., Cisplatin).
- Radiotherapy (total body irradiation or abdominal fraction).
- Post-operative recovery (Gynecological, Abdominal surgery).
Dosage & Administration
Strict Medical Supervision Required:
- Chemotherapy (Adults): 8 mg to 32 mg IV slow injection (over 15 mins) prior to chemotherapy.
- Post-Operative (Adults): 4 mg IV slow injection immediately before induction of anesthesia.
- Pediatrics: Dosing based on body surface area (BSA) or weight (0.15 mg/kg).
Compatibility:
- Compatible with: 0.9% Sodium Chloride, 5% Dextrose, Ringer’s Injection.
Commercial Inquiries
For hospital tenders, bulk export, or distributor pricing, please contact our export team.
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in